Mechanical loading of bone maintains bone mass and skeletal integrity. Loading stimulates new bone formation and unloading causes bone loss. Cyclooxygenase (COX)-2, the major enzyme for prostaglandin (PG) responses in bone, can enhance both bone formation and resorption and may mediate some effects of either loading or unloading. Our overall goal is to understand how mechanical signals are transmitted into biochemical signals and the role of COX-2 in these processes. Mechanical strains in bone can generate interstitial fluid flow that exerts fluid shear stress (FSS) on cells and induces COX-2. Because in vivo studies suggest that effects of short duration loading are not improved by longer duration, we believe the signaling cascade after removal of FSS will be important for determining outcomes of loading. In vitro, we will examine responses of COX-2, and selected other genes important for bone turnover, in osteoblastic and osteocytic cells during and after stopping FSS. We will determine if the protein kinase D (PKD) pathway mediates the FSS induction of COX-2 via activation of ERK after stopping FSS;if the transcription factors Cbfa1 (Runx2) and NFAT are mediators of the FSS induction of COX-2 transcription;and if the development of COX-2 expression after FSS also depends on regulation of mRNA stability. We will assess the role of COX-2 produced PGs, induced by FSS, in FSS effects on other genes using nonsteroidal anti-inflammatory drugs (NSAIDs) and cells derived from Cox-2+/+ and Cox-2-/- mice. In vivo, we will study effects of dynamic axial loading of the ulnae and effects of unloading of hind limbs by tail suspension. We will use mice with Cox-2 deletion conditionally targeted to osteoblastic and osteocytic cells with the 2.3-kb Co1a1 promoter driving Cre recombinase (Col1a1-Cre) or the 2.3-kb Col1a1 promoter driving Cre recombinase fused to a mutated ligand binding domain of the estrogen receptor (Col1a1-CreERT2), which becomes active only after administration of the synthetic estrogen antagonist 4-hydroxy-tamoxifen. We will examine potential compensation by cyclooxygenase (COX)-1 for absent COX-2 by comparing targeted Cox-2 deletion in Cox- 1+/+ and Cox-1-/- mice. We will measure bone gain or loss and gene expression at intervals after loading or unloading to determine effects of Cox-2 deletion (+/- Cox-1 deletion) on the response of other genes that may mediate effects of loading and unloading. Public health relevance: Physical activity that mechanically loads bone can increase bone mass and decrease bone loss. Osteoporosis, associated with bone loss and leading to debilitating skeletal fractures, increases with age and physical inactivity. A better understanding of how mechanical loading regulates bone may help us to develop better therapies for prevention and treatment of osteoporosis.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
5R01AR047673-09
Application #
7880133
Study Section
Skeletal Biology Structure and Regeneration Study Section (SBSR)
Program Officer
Sharrock, William J
Project Start
2001-04-11
Project End
2012-06-30
Budget Start
2010-07-01
Budget End
2012-06-30
Support Year
9
Fiscal Year
2010
Total Cost
$306,737
Indirect Cost
Name
University of Connecticut
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
022254226
City
Farmington
State
CT
Country
United States
Zip Code
06030
Choudhary, Shilpa; Blackwell, Katherine; Voznesensky, Olga et al. (2013) Prostaglandin E2 acts via bone marrow macrophages to block PTH-stimulated osteoblast differentiation in vitro. Bone 56:31-41
Xu, Manshan; Choudhary, Shilpa; Voznesensky, Olga et al. (2010) Basal bone phenotype and increased anabolic responses to intermittent parathyroid hormone in healthy male COX-2 knockout mice. Bone 47:341-52
Blackwell, Katherine A; Raisz, Lawrence G; Pilbeam, Carol C (2010) Prostaglandins in bone: bad cop, good cop? Trends Endocrinol Metab 21:294-301
Gao, Qi; Xu, Manshan; Alander, Cynthia B et al. (2009) Effects of prostaglandin E2 on bone in mice in vivo. Prostaglandins Other Lipid Mediat 89:20-5
Igwe, John C; Jiang, Xi; Paic, Frane et al. (2009) Neuropeptide Y is expressed by osteocytes and can inhibit osteoblastic activity. J Cell Biochem 108:621-30
Plotnikov, Sergey V; Kenny, Anne M; Walsh, Stephen J et al. (2008) Measurement of muscle disease by quantitative second-harmonic generation imaging. J Biomed Opt 13:044018
Mehrotra, Meenal; Saegusa, Masatomo; Voznesensky, Olga et al. (2006) Role of Cbfa1/Runx2 in the fluid shear stress induction of COX-2 in osteoblasts. Biochem Biophys Res Commun 341:1225-30
Mehrotra, Meenal; Saegusa, Masatomo; Wadhwa, Sunil et al. (2006) Fluid flow induces Rankl expression in primary murine calvarial osteoblasts. J Cell Biochem 98:1271-83
Xu, Manshan; Choudhary, Shilpa; Goltzman, David et al. (2005) Do cyclooxygenase-2 knockout mice have primary hyperparathyroidism? Endocrinology 146:1843-53
Mehrotra, Meenal; Krane, Stephen M; Walters, Kristen et al. (2004) Differential regulation of platelet-derived growth factor stimulated migration and proliferation in osteoblastic cells. J Cell Biochem 93:741-52

Showing the most recent 10 out of 12 publications